Stimcell Energetics (STME) Shareholder's Equity (QoQ) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Stimcell Energetics | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | -8.83% |
| Nov 30, 2025 | -10.64% |
| Aug 31, 2025 | -11.85% |
| May 31, 2025 | -16.45% |
| Feb 28, 2025 | -8.91% |
| Nov 30, 2024 | -8.14% |
| Aug 31, 2024 | -9.96% |
| May 31, 2024 | -16.41% |
| Feb 29, 2024 | 71.89% |
| Nov 30, 2023 | -2.19% |
| Aug 31, 2023 | -3.60% |
| May 31, 2023 | -3.51% |
| Feb 28, 2023 | -4.79% |
| Nov 30, 2022 | -4.50% |
| Aug 31, 2022 | -4.76% |
| May 31, 2022 | -9.20% |
| Feb 28, 2022 | -7.68% |
| Nov 30, 2021 | -9.94% |
| Aug 31, 2021 | 1.40% |
| May 31, 2021 | 16.59% |
| Feb 28, 2021 | -12.22% |
| Nov 30, 2020 | -13.22% |
| Aug 31, 2020 | 2.18% |
| May 31, 2020 | -3.65% |
| Feb 29, 2020 | -199.94% |
| Nov 30, 2019 | 26.02% |
| Aug 31, 2019 | 165.70% |
| May 31, 2019 | -8.19% |
| Feb 28, 2019 | -14.01% |
| Nov 30, 2018 | -9.20% |
| Aug 31, 2018 | -22.60% |
| May 31, 2018 | -27.99% |
| Feb 28, 2018 | -38.55% |
| Nov 30, 2017 | 41.29% |
| Aug 31, 2017 | 11.83% |
| May 31, 2017 | -51.52% |
| Feb 28, 2017 | -53.79% |
| Nov 30, 2016 | 69.45% |
| Aug 31, 2016 | -16.27% |
| May 31, 2016 | -17.65% |
| May 31, 2013 | -407.61% |
| Feb 28, 2013 | -106.17% |
| May 31, 2012 | -17.56% |
| Feb 29, 2012 | 201.80% |
| Nov 30, 2011 | -84.66% |
| Aug 31, 2011 | -105.99% |